Claraphi Advisory Network’s ARK Genomic Revolution ETF ARKG Stock Holding History

Claraphi Advisory Network’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2.34M	Buy	82,732 +26,068	+46%	+$827K	0.93%	28
2022 Q3	$1.86M	Sell	56,664 -13,413	-19%	-$492K	1.01%	20
2022 Q2	$2.21M	Sell	70,077 -18,926	-21%	-$662K	0.78%	28
2022 Q1	$4.09M	Sell	89,003 -77,863	-47%	-$3.71M	1.18%	14
2021 Q4	$10.2M	Sell	166,866 -18,587	-10%	-$1.28M	3.56%	4
2021 Q3	$13.9M	Sell	185,453 -88,110	-32%	-$7.39M	4.89%	4
2021 Q2	$25.3M	Sell	273,563 -92,541	-25%	-$7.87M	7.62%	2
2021 Q1	$32.5M	Sell	366,104 -39,088	-10%	-$3.88M	8.95%	2
2020 Q4	$37.8M	Buy	405,192 +99,793	+33%	+$7.95M	10.29%	2
2020 Q3	$19.5M	Buy	305,399 +39,164	+15%	+$2.29M	7.05%	2
2020 Q2	$13.9M	Buy	266,235 +165,646	+165%	+$7.1M	5.92%	2
2020 Q1	$3.15M	Sell	100,589 -41,098	-29%	-$1.37M	1.49%	10
2019 Q4	$4.75M	Sell	141,687 -626	-0.4%	-$19.9K	2.91%	7
2019 Q3	$4.2M	Buy	142,313 +78,844	+124%	+$2.56M	2.54%	7
2019 Q2	$2.19M	Buy	63,469 +36,476	+135%	+$1.17M	1.28%	11
2019 Q1	$888K	Buy	+26,993	New	+$797K	0.56%	34

Other funds holding ARKG

AWA

Arete Wealth Advisors Chicago, Illinois $3.05B AUM 42.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Claraphi Advisory Network's ARKG Position: Q4 2022 in Review

Claraphi Advisory Network increased its ARK Genomic Revolution ETF (ARKG) stake by 46% in Q4 2022, buying an estimated $827K and bringing the position to 82,732 shares worth $2.34M. The position accounts for 0.93% of the portfolio, ranked #28.

Claraphi Advisory Network first reported a position in ARKG in Q1 2019 and has held it in 16 quarters since. The position peaked at $37.8M in Q4 2020. 321 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

Claraphi Advisory Network held 82,732 shares of ARK Genomic Revolution ETF worth $2.34M as of Q4 2022.
Claraphi Advisory Network bought 26,068 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $827K.
ARK Genomic Revolution ETF made up 0.93% of Claraphi Advisory Network's portfolio in Q4 2022, its #28 holding.
Claraphi Advisory Network first reported a position in ARK Genomic Revolution ETF in Q1 2019 and has held it in 16 quarters since.
Claraphi Advisory Network's ARK Genomic Revolution ETF position peaked at $37.8M in Q4 2020.
321 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Claraphi Advisory Network's 13F filing for Q4 2022, filed 14 Feb 2023.